HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use AROMASIN safely and effectively. See full prescribing information for AROMASIN.
AROMASIN® (exemestane) tablets, for oral use
Initial U.S. Approval: 1999
INDICATIONS AND USAGE
AROMASIN is an aromatase inhibitor indicated for:
DOSAGE AND ADMINISTRATION
Recommended Dose: One 25 mg tablet once daily after a meal (2.1).
DOSAGE FORMS AND STRENGTHS
Tablets: 25 mg (3)
Patients with a known hypersensitivity to the drug or to any of the excipients (4).
WARNINGS AND PRECAUTIONS
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
USE IN SPECIFIC POPULATIONS
Lactation: Advise not to breastfeed (8.2).
See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.